High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study

Abstract

This study assessed the characteristics and the relationship between symptoms in any part of the 24-hour (24-h) day, physical activity level (PAL), and other clinical and functional outcomes in stable COPD patients. Patients and Methods: Out of the 2162 patients enrolled in the SPACE study (The Symptoms and Physical Activity in COPD patients in Europe, clinicaltrials.gov NCT03031769), 406 (18.8%) were recruited from Romania. Here, we present the Romanian cohort results. Eligible patients were adults with age at least 40 years, confirmed diagnosis of stable COPD, current or former smokers with a smoking history of minimum 10 pack-years. The 24-h respiratory symptoms were assessed using Early Morning Symptoms of COPD Instrument (EMSCI), Evaluating Respiratory Symptoms in COPD (E-RS™: COPD) and Nighttime Symptoms of COPD Instrument (NiSCI). During clinical interview, patients self-evaluated PAL through Exercise as Vital Sign (EVS) and Yale Physical Activity Survey (YPAS). Physicians assessed PAL through their clinical judgment. Results: For each combination of 2 between the early morning (EM), daytime (DT) and night-time (NT) symptoms of the 24-h day, there was a significant association (p < 0.001 for each). All symptoms significantly correlated with exacerbation history (p < 0.001 for EM and NT, p=0.002 for DT), and number of severe exacerbations (p < 0.001 for DT, p=0.001 for EM and p=0.026 for NT, respectively). The 24-h symptoms correlated negatively and significantly with PAL (p < 0.001), irrespective of the assessment used. Self-reported PAL negatively correlated with dyspnea, symptom burden, severity of disease and number of exacerbations (p < 0.001). Patients spent an average (standard deviation) of 25.8 (21.0) hours/week performing physical activity. Physicians overestimated their patients' daily PAL. Conclusion:A negative and significant correlation between the 24-h day symptoms and PAL was identified in stable COPD patients. Physicians need to routinely assess PAL using adequate tools and start educating inactive COPD patients to optimize their disease outcomes.

Effects of physical activity and sedentary behavior on serum vitamin D in patients with chronic obstructive pulmonary disease

“…Values are presented as OR (95% CI). Sedentary behavior and decreased physical activity due to exertional dyspnea are one of the main life characteristics of patients with COPD, and this lifestyle is associated with poor outcomes in patients with COPD 34 : physical activity level and health status of patients with COPD, 35 the symptom burden, [36][37][38] prolonged sedentary time, and decreased physical activity levels can all affect the mortality rate and the number of exacerbations 39 in patients with COPD. A study with a mean follow-up of 2.7 years found that the number of daily steps in patients with COPD decreased periodically over time, and this change was significantly correlated with the degree of airflow limitation in patients with COPD.…”

Clinical Features and Paraclinical Findings in Patients with SARS CoV-2 Pneumonia and the Impact of Pulmonary Rehabilitation on the Instrumental Activities of Daily Living in POST-COVID-19 Patients

“…It would be even more beneficial to each patient if this program could be multidisciplinary or cross-domain, covering multiple specialties and extending far beyond hospital care to community rehabilitation services as well, with the inclusion of tertiary, secondary, and/or primary-care facilities/levels. Some experts recommend, according to COVID-19’s clinical signs and symptoms, that the patient’s rehabilitation has to include pulmonary, physical, and psychosocial rehabilitation, as in chronic obstructive pulmonary disease (COPD) [ 17 , 18 , 19 , 20 ].…”

Clinical effect of aerobic exercise training in chronic obstructive pulmonary disease: A retrospective study

“…Patients with stable COPD, still feel fatigued, dizzy and often shortness of breath despite all medical treatments. [ 4 ] In addition, all the treatments mentioned above may lead to certain side effects of drugs, such as heart toxicity, risks of pneumonia, or gastrointestinal adverse reactions. [ 5 ] The pathophysiological basis of fatigue in COPD is complex, and its precise mechanisms remain unknown.…”